Skip to main content
. 2017 Apr;46(4):517–524.

Fig. 1:

Fig. 1:

Effect of folic acid supplementation on Percentile variations in serum osteoprotegerin (OPG), soluble receptor activator of nuclear factor-kappa B ligand (sRANKL) and tumor necrosis factor alpha (TNFα) at the end of study between group 1(5mg/day) vs. group 2 (0.5mg/day)(mean)